CSR Analysis Cherry Biotech
cherrybiotech.comDevelopment of 3D cell culture technologies for biomedical research, including organoid models and microphysiological systems for drug development and personalized medicine.
Development of 3D cell culture technologies for biomedical research, including organoid models and microphysiological systems for drug development and personalized medicine.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Cherry Biotech's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: August 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Ctibiotech
B
Development of advanced human tissue models for biomedical research, cosmetic, and pharmaceutical testing using stem cells and 3D printing technologies.
Lattice MEDICAL
B
Development of innovative medical devices for reconstructive surgery using biomaterials, tissue engineering, and 3D printing.
MB Therapeutics
B
Development and production of personalized medicines using 3D printing, customizing dosage, shape, and combining multiple active ingredients.
Initiatives identified among leaders
Financement de 6M€ pour développer MATTISSE et impression 3D d'implants mammaires.
“LATTICE MEDICAL a obtenu un financement de 6 milli...” - Lattice MEDICALLancement d'une solution industrielle d'impression 3D de médicaments personnalisés en pharmacie.
“MB Therapeutics a levé 2 millions d'euros lors de ...” - MB TherapeuticsStructuration de la RSE via Med-Transitions pour aligner performance et responsabilité.
“MB Therapeutics a participé au programme Med-Trans...” - MB Therapeutics46% of similar organizations communicate on CSR issues
+124 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports
